Stratus Therapeutics
United States · $50.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- stratustx.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series AMar 2025
- Rounds
- 1
About
Biotechnology company developing on-demand, off-the-shelf hematopoietic stem cell therapies for serious blood disorders.
Summary
Stratus Therapeutics is a Biotech company based in United States. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in Mar 2025. Investors include Kyowa Kirin, Alexandria Venture Investments and OrbiMed.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...